Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G Gross

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Pediatric Blood & Cancer|April 16, 2011
Pediatric indolent lymphoma--would less be better?Sherrie L Perkins, Thomas G Gross
Pediatric Hematology and Oncology|June 14, 2013
Anaplastic large cell lymphoma in children and adolescentsEric J Lowe, Thomas G Gross
Pediatric Blood & Cancer|March 20, 2023
Reply to: Stand with UkrainePeter E Newburger, Thomas G Gross
Hematological Oncology|June 9, 2023
Post-transplant lymphoproliferative disease in children, adolescents, and young adultsThomas G Gross, Jeremy D Rubinstein
Pediatric Clinics of North America|April 8, 2010
Posttransplant lymphoproliferative diseasesThomas G Gross, Barbara Savoldo, Angela Punnett
Pediatric Hematology and Oncology|June 28, 2013
Post-transplant lymphoproliferative disease in pediatric solid organ transplant recipientsBirte Wistinghausen, Thomas G Gross, Catherine Bollard
Hematology. American Society of Hematology. Education Program|November 10, 2001
Atypical Lymphoproliferative DiseasesTimothy Greiner, James O. Armitage, Thomas G. Gross
Pediatric Blood & Cancer|June 7, 2022
Discordance between detection of MYC rearrangement by immunohistochemistry versus fluorescent in situ hybridization in Burkitt lymphomaAlexander W Rankin, Bradford Siegele, Thomas G Gross
Seminars in Hematology|January 30, 2010
Transplant outcomes for primary immunodeficiency diseaseAngela R Smith, Thomas G Gross, K Scott Baker
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: non-Hodgkin lymphomaCatherine M Bollard, Megan S Lim, Thomas G Gross, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Pediatric Blood & Cancer|April 16, 2011
Pediatric indolent lymphoma--would less be better?Sherrie L Perkins, Thomas G Gross
Pediatric Hematology and Oncology|June 14, 2013
Anaplastic large cell lymphoma in children and adolescentsEric J Lowe, Thomas G Gross
Pediatric Blood & Cancer|March 20, 2023
Reply to: Stand with UkrainePeter E Newburger, Thomas G Gross
Hematological Oncology|June 9, 2023
Post-transplant lymphoproliferative disease in children, adolescents, and young adultsThomas G Gross, Jeremy D Rubinstein
Pediatric Clinics of North America|April 8, 2010
Posttransplant lymphoproliferative diseasesThomas G Gross, Barbara Savoldo, Angela Punnett
Pediatric Hematology and Oncology|June 28, 2013
Post-transplant lymphoproliferative disease in pediatric solid organ transplant recipientsBirte Wistinghausen, Thomas G Gross, Catherine Bollard
Hematology. American Society of Hematology. Education Program|November 10, 2001
Atypical Lymphoproliferative DiseasesTimothy Greiner, James O. Armitage, Thomas G. Gross
Pediatric Blood & Cancer|June 7, 2022
Discordance between detection of MYC rearrangement by immunohistochemistry versus fluorescent in situ hybridization in Burkitt lymphomaAlexander W Rankin, Bradford Siegele, Thomas G Gross
Seminars in Hematology|January 30, 2010
Transplant outcomes for primary immunodeficiency diseaseAngela R Smith, Thomas G Gross, K Scott Baker
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: non-Hodgkin lymphomaCatherine M Bollard, Megan S Lim, Thomas G Gross, et al.
Pageof 11